Compare

Aethlon Medical Inc vs GeoVax Labs, Inc. vs Vyome Holdings, Inc vs OS Therapies Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAethlon Medical Inc
AEMD
GeoVax Labs, Inc.
GOVX
Vyome Holdings, Inc
HIND
OS Therapies Inc
OSTX
Year ended2026-03-312025-12-312025-12-312025-12-31
Revenuen/a$2.49M$319.7Kn/a
Revenue growth (YoY)n/a-37.1%+24.4%n/a
Gross marginn/an/a68.4%n/a
Operating marginn/a-869.3%n/mn/a
Net marginn/a-862.3%n/mn/a
Net income-$7.15M-$21.46M-$10.26M-$28.75M
EPS (Diluted)-$10.61n/a-$4.86-$0.98
Operating cash flow-$7.00M-$21.47M-$3.75M-$14.24M
Free cash flow-$7.00M-$21.50Mn/a-$14.70M
Cash & equivalents$5.03M$3.09M$4.98Mn/a
Total assets$6.33M$6.34M$6.50M$6.84M
Total liabilities$1.45M$2.52M$2.74M$11.86M
Shareholders' equity$4.89M$3.83M$3.76M-$6.10M
Return on year-end equity-146.4%-561.2%-272.8%n/a
Shares outstanding1.57M1.73M5.92M37.11M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAethlon Medical IncGeoVax Labs, Inc.Vyome Holdings, IncOS Therapies Inc
Latest$0
Ended 2024-03-31
$2.49M
Ended 2025-12-31
$319.7K
Ended 2025-12-31
n/a
1 year earlier$574.2K
Ended 2023-03-31
$3.95M
Ended 2024-12-31
$256.9K
Ended 2024-12-31
n/a
2 years earlier$294.2K
Ended 2022-03-31
$0
Ended 2023-12-31
$8.68M
Ended 2023-12-31
n/a
3 years earlier$659.1K
Ended 2021-03-31
$81.5K
Ended 2022-12-31
$11.24M
Ended 2022-12-31
n/a
4 years earlier$650.2K
Ended 2020-03-31
$385.5K
Ended 2021-12-31
$13.60M
Ended 2021-12-31
n/a